Blood biomarkers for cardiac damage during and after radiotherapy for esophageal cancer: A prospective cohort study.

Autor: Beukema JC; Department of Radiation oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: j.c.beukema@umcg.nl., Haveman JW; Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Langendijk JA; Department of Radiation oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Oldehinkel E; Department of Radiation oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., van den Bergh ACM; Antoni van Leeuwenhoek Netherlands Cancer Institute, Amsterdam, the Netherlands., de Haan JJ; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., van Melle JP; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., van Luijk P; Department of Radiation oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Muijs CT; Department of Radiation oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Nov; Vol. 200, pp. 110479. Date of Electronic Publication: 2024 Aug 18.

Late cardiac toxicity of neo-adjuvant chemoradiation in esophageal cancer survivors: A prospective cross-sectional pilot study.

Autor: Beukema JC; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands. Electronic address: j.c.beukema@umcg.nl., de Groot C; Department of Radiation Oncology, Isala Hospital, Zwolle, The Netherlands., Plukker JTM; Department of Surgery, University Medical Center Groningen, University of Groningen, The Netherlands., Vliegenthart R; Department of Radiology, University Medical Center Groningen, University of Groningen, The Netherlands., Langendijk JA; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands., van Luijk P; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands., van Melle JP; Department of Cardiology, University Medical Center Groningen, University of Groningen, The Netherlands., Prakken NHJ; Department of Radiology, University Medical Center Groningen, University of Groningen, The Netherlands., Muijs CT; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2022 Feb; Vol. 167, pp. 72-77. Date of Electronic Publication: 2021 Dec 02.

Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study.

Autor: van Triest B; Netherlands Cancer institute, Department of Radiotherapy, Amsterdam, Netherlands. Electronic address: b.v.triest@nki.nl., Rasing M; University Medical Center Utrecht, Department of Radiation Oncology Utrecht, Netherlands., van der Velden J; Amsterdam University Medical Center, Department of Gynaecology, Amsterdam, Netherlands., de Hullu J; Radboud University Medical Center, Department of Gynaecology, Nijmegen, Netherlands., Witteveen PO; University Medical Center Utrecht, Department of Medical Oncology, Utrecht, Netherlands., Beukema JC; University Medical Center Groningen, Department of Radiotherapy, Groningen, Netherlands., van der Steen-Banasik E; Radiotherapie Groep, Deventer/Arnhem, Netherlands., Westerveld H; Amsterdam University Medical Center, Department of Radiotherapy, Amsterdam, Netherlands., Snyers A; Radboud University Medical Center, Department of Radiation Oncology, Nijmegen, Netherlands., Peters M; University Medical Center Utrecht, Department of Radiation Oncology Utrecht, Netherlands., Creutzberg CL; Leiden University Medical Center, Department of Radiotherapy, Leiden, Netherlands., Nout RA; Erasmus University Medical Center, Department of Radiotherapy, Rotterdam, Netherlands., Lutgens L; Maastricht Radiation Therapy and Oncology clinic (Maastro), Maastricht, Netherlands., Jürgenliemk-Schulz I; University Medical Center Utrecht, Department of Radiation Oncology Utrecht, Netherlands.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2021 Oct; Vol. 163 (1), pp. 117-124. Date of Electronic Publication: 2021 Jul 21.

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.

Autor: Eyck BM; Department of Surgery, Erasmus Medical Center Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands., van Lanschot JJB; Department of Surgery, Erasmus Medical Center Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.; Formerly at Department of Surgery, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Hulshof MCCM; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., van der Wilk BJ; Department of Surgery, Erasmus Medical Center Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands., Shapiro J; Department of Surgery, Erasmus Medical Center Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands., van Hagen P; Department of Surgery, Erasmus Medical Center Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands., van Berge Henegouwen MI; Department of Surgery, Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Wijnhoven BPL; Department of Surgery, Erasmus Medical Center Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands., van Laarhoven HWM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Nieuwenhuijzen GAP; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands., Hospers GAP; Comprehensive Cancer Center, University of Groningen-University Medical Center Groningen, Groningen, the Netherlands., Bonenkamp JJ; Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands., Cuesta MA; Department of Surgery, Amsterdam University Medical Centers, Location VUmc, Amsterdam, the Netherlands., Blaisse RJB; Department of Medical Oncology, Rijnstate Hospital, Arnhem, the Netherlands., Busch OR; Department of Surgery, Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Creemers GM; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands., Punt CJA; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.; Formerly at Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Plukker JTM; Department of Surgery, University of Groningen-University Medical Center Groningen, Groningen, the Netherlands., Verheul HMW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Formerly at Department of Medical Oncology, Amsterdam University Medical Centers, Location VUmc, Amsterdam, the Netherlands., Spillenaar Bilgen EJ; Department of Surgery, Rijnstate Hospital, Arnhem, the Netherlands., van der Sangen MJC; Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands., Rozema T; Verbeeten Institute, Tilburg, the Netherlands.; Formerly at Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Ten Kate FJW; Formerly at Department of Pathology, Erasmus MC-University Medical Center Rotterdam, the Netherlands., Beukema JC; Department of Radiation Oncology, University of Groningen-University Medical Center Groningen, Groningen, the Netherlands., Piet AHM; Department of Radiation Oncology, Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands., van Rij CM; Department of Radiation Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands., Reinders JG; Arnhem Radiotherapeutic Institute ARTI, Arnhem, the Netherlands., Tilanus HW; Formerly at Department of Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands., Steyerberg EW; Department of Public Health, Erasmus MC-University Medical Center Rotterdam, Rotterdam, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands., van der Gaast A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Jun 20; Vol. 39 (18), pp. 1995-2004. Date of Electronic Publication: 2021 Apr 23.

Clinical selection strategy for and evaluation of intra-operative brachytherapy in patients with locally advanced and recurrent rectal cancer.

Autor: Dijkstra EA; University of Groningen, University Medical Centre Groningen, Department of Medical Oncology, the Netherlands., Mul VEM; University of Groningen, University Medical Centre Groningen, Department of Radiation Oncology, the Netherlands., Hemmer PHJ; University of Groningen, University Medical Centre Groningen, Department of Surgery, the Netherlands., Havenga K; University of Groningen, University Medical Centre Groningen, Department of Surgery, the Netherlands., Hospers GAP; University of Groningen, University Medical Centre Groningen, Department of Medical Oncology, the Netherlands., Kats-Ugurlu G; University of Groningen, University Medical Centre Groningen, Department of Pathology and Medical Biology, the Netherlands., Beukema JC; University of Groningen, University Medical Centre Groningen, Department of Radiation Oncology, the Netherlands., Berveling MJ; University of Groningen, University Medical Centre Groningen, Department of Radiation Oncology, the Netherlands., El Moumni M; University of Groningen, University Medical Centre Groningen, Department of Surgery, the Netherlands., Muijs CT; University of Groningen, University Medical Centre Groningen, Department of Radiation Oncology, the Netherlands., van Etten B; University of Groningen, University Medical Centre Groningen, Department of Surgery, the Netherlands. Electronic address: b.van.etten@umcg.nl.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Jun; Vol. 159, pp. 91-97. Date of Electronic Publication: 2021 Mar 17.